Related Experiment Video

Updated: May 7, 2026

Cultivation Methods of Spirochetes from Borrelia burgdorferi Sensu Lato Complex and Relapsing Fever Borrelia
10:37

Cultivation Methods of Spirochetes from Borrelia burgdorferi Sensu Lato Complex and Relapsing Fever Borrelia

Published on: November 25, 2022

Familial Mediterranean fever: a critical digest of the 2012-2013 literature

Eli M Eisenstein1, Yakov Berkun, Eldad Ben-Chetrit

  • 1Department of Pediatrics, Hadassah-Hebrew University Medical Center, Jerusalem, Israel. eisenstein@hadassah.org.il.

Clinical and Experimental Rheumatology
|September 26, 2013
PubMed

Insights

Recent research offers new insights into Familial Mediterranean Fever (FMF) mechanisms and diagnosis. Novel treatments targeting interleukin-1 show promise for colchicine-resistant FMF patients.

Area of Science:

  • Immunology
  • Genetics
  • Rheumatology

Background:

  • Familial Mediterranean Fever (FMF) is a genetic autoinflammatory disorder.
  • Pyrin mutations are implicated in FMF pathogenesis.
  • Understanding FMF mechanisms is crucial for effective management.

Purpose of the Study:

  • To review recent advancements in Familial Mediterranean Fever (FMF) research from 2012-2013.
  • To discuss the clinical significance of new findings for healthcare providers.
  • To highlight progress in understanding FMF mechanisms, diagnosis, and treatment.

Main Methods:

  • Literature review of recent studies on Familial Mediterranean Fever (FMF).
  • Analysis of research on pyrin mutation mechanisms.
  • Evaluation of new diagnostic guidelines and treatment trial results.

Main Results:

  • New insights into pyrin mutation mechanisms causing FMF autoinflammatory phenotype.
  • Availability of evidence-based diagnostic guidelines, including genetic testing.
  • Partial definition of colchicine resistance risks.
  • Demonstrated efficacy of interleukin-1 antagonists for colchicine-resistant/intolerant FMF.

Conclusions:

  • Significant progress in understanding FMF mechanisms and diagnosis.
  • Interleukin-1 antagonists represent a promising therapeutic option for refractory FMF.
  • Recent findings have important implications for clinical practice in managing FMF.

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Patterns of Fever01:26

Patterns of Fever

Before understanding the types and patterns of fever, it is essential to know its phases.
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Methods of reducing fever01:22

Methods of reducing fever

The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...